Latest & greatest articles for fluoxetine

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on fluoxetine or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on fluoxetine and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for fluoxetine

21. Combined fluoxetine plus cognitive behavioural therapy is more effective than monotherapy or placebo for adolescents with depression

Combined fluoxetine plus cognitive behavioural therapy is more effective than monotherapy or placebo for adolescents with depression Combined fluoxetine plus cognitive behavioural therapy is more effective than monotherapy or placebo for adolescents with depression | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please (...) see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Combined fluoxetine plus cognitive behavioural therapy is more effective than monotherapy or placebo for adolescents

2008 Evidence-Based Mental Health

22. Combined olanzapine plus fluoxetine modestly improves symptoms of acute bipolar I depression compared to lamotrigine

Combined olanzapine plus fluoxetine modestly improves symptoms of acute bipolar I depression compared to lamotrigine Combined olanzapine plus fluoxetine modestly improves symptoms of acute bipolar I depression compared to lamotrigine | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Combined olanzapine plus fluoxetine modestly improves symptoms of acute bipolar I depression compared to lamotrigine Article Text Therapeutics Combined

2008 Evidence-Based Mental Health

23. Light therapy and fluoxetine similarly effective for improving seasonal affective disorder

Light therapy and fluoxetine similarly effective for improving seasonal affective disorder Light therapy and fluoxetine similarly effective for improving seasonal affective disorder | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Light therapy and fluoxetine similarly effective for improving seasonal affective disorder Article Text Therapeutics Light therapy and fluoxetine similarly effective for improving seasonal affective disorder Statistics

2008 Evidence-Based Mental Health

24. The treatment of major depressive disorders (MDD) in Thailand using escitalopram compared to fluoxetine and venlafaxine: a pharmacoeconomic evaluation

The treatment of major depressive disorders (MDD) in Thailand using escitalopram compared to fluoxetine and venlafaxine: a pharmacoeconomic evaluation The treatment of major depressive disorders (MDD) in Thailand using escitalopram compared to fluoxetine and venlafaxine: a pharmacoeconomic evaluation The treatment of major depressive disorders (MDD) in Thailand using escitalopram compared to fluoxetine and venlafaxine: a pharmacoeconomic evaluation Kongsakon R, Bunchapattanasakda C Record (...) Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The objective was to assess the cost-effectiveness of escitalopram versus fluoxetine and venlafaxine for the treatment of major depressive disorder. The authors concluded that escitalopram was more

2008 NHS Economic Evaluation Database.

25. Olanzapine plus fluoxetine reduce depressive symptoms faster than either drug alone in people with treatment resistant depression

Olanzapine plus fluoxetine reduce depressive symptoms faster than either drug alone in people with treatment resistant depression Olanzapine plus fluoxetine reduce depressive symptoms faster than either drug alone in people with treatment resistant depression | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our (...) . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Olanzapine plus fluoxetine reduce depressive symptoms faster than either drug alone in people with treatment resistant depression

2007 Evidence-Based Mental Health

26. Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study. Full Text available with Trip Pro

Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study. To compare the risk of suicide in adults using the antidepressant venlafaxine compared with citalopram, fluoxetine, and dothiepin.Retrospective cohort study.UK General Practice Research Database.219,088 patients, aged 18-89 years, who were prescribed venlafaxine, citalopram, fluoxetine, or dothiepin from 1995 to 2005.Completed suicide and attempted suicide.Venlafaxine users had (...) a higher burden of risk factors for suicide, including previous suicide attempts and proxies for severe depression or depression that was difficult to treat. In the analysis for completed suicides, unadjusted and adjusted hazard ratios for venlafaxine compared with citalopram were 2.44 (95% confidence interval 1.12 to 5.31) and 1.70 (0.76 to 3.80), for venlafaxine compared with fluoxetine were 2.85 (1.37 to 5.94) and 1.63 (0.74 to 3.59), and for venlafaxine compared with dothiepin were 2.54 (1.07

2007 BMJ

27. Eye movement desensitisation and reprocessing reduces PTSD symptoms compared with fluoxetine at six months post-treatment

Eye movement desensitisation and reprocessing reduces PTSD symptoms compared with fluoxetine at six months post-treatment Eye movement desensitisation and reprocessing reduces PTSD symptoms compared with fluoxetine at six months post-treatment | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using (...) your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Eye movement desensitisation and reprocessing reduces PTSD symptoms compared with fluoxetine at six months post-treatment Article Text

2007 Evidence-Based Mental Health

28. Continuing fluoxetine treatment may delay relapse in children and adolescents with major depressive disorder Full Text available with Trip Pro

Continuing fluoxetine treatment may delay relapse in children and adolescents with major depressive disorder Continuing fluoxetine treatment may delay relapse in children and adolescents with major depressive disorder | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Continuing fluoxetine treatment may delay relapse in children and adolescents with major depressive disorder Article Text Therapeutics Continuing fluoxetine treatment may delay

2006 Evidence-Based Mental Health

29. Fluoxetine improves minor depressive disorders Full Text available with Trip Pro

Fluoxetine improves minor depressive disorders Fluoxetine improves minor depressive disorders | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search (...) for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Fluoxetine improves minor depressive disorders Article Text Therapeutics Fluoxetine improves minor depressive disorders Free Philip J Cowen , MD, FRCPsych Statistics from Altmetric.com Judd LL, Rapaport MH, Yonkers KA, et al . Randomized, placebo-controlled trial of fluoxetine for acute treatment

2006 Evidence-Based Mental Health

30. Fluoxetine plus cognitive behavioural therapy was most effective for adolescents with major depressive disorder Full Text available with Trip Pro

Fluoxetine plus cognitive behavioural therapy was most effective for adolescents with major depressive disorder Fluoxetine plus cognitive behavioural therapy was most effective for adolescents with major depressive disorder | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Fluoxetine plus cognitive behavioural therapy was most effective for adolescents with major depressive disorder Article Text Therapeutics Fluoxetine plus cognitive

2006 Evidence-Based Medicine

31. Fluoxetine plus cognitive behavioural therapy was most effective for adolescents with major depressive disorder Full Text available with Trip Pro

Fluoxetine plus cognitive behavioural therapy was most effective for adolescents with major depressive disorder Fluoxetine plus cognitive behavioural therapy was most effective for adolescents with major depressive disorder | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Fluoxetine plus cognitive behavioural therapy was most effective for adolescents with major depressive disorder Article Text Treatment Fluoxetine plus cognitive behavioural therapy

2006 Evidence-Based Nursing

32. Fluoxetine plus cognitive behavioural therapy improves symptoms of major depressive disorder in adolescents Full Text available with Trip Pro

Fluoxetine plus cognitive behavioural therapy improves symptoms of major depressive disorder in adolescents Fluoxetine plus cognitive behavioural therapy improves symptoms of major depressive disorder in adolescents | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Fluoxetine plus cognitive behavioural therapy improves symptoms of major depressive disorder in adolescents Article Text Therapeutics Fluoxetine plus cognitive behavioural therapy

2006 Evidence-Based Mental Health

33. Review: fluoxetine, orlistat, and sibutramine modestly reduce weight in type 2 diabetes Full Text available with Trip Pro

Review: fluoxetine, orlistat, and sibutramine modestly reduce weight in type 2 diabetes Review: fluoxetine, orlistat, and sibutramine modestly reduce weight in type 2 diabetes | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: fluoxetine, orlistat, and sibutramine modestly reduce weight in type 2 diabetes Article Text Therapeutics Review: fluoxetine, orlistat, and sibutramine modestly reduce weight in type 2 diabetes Free Christopher

2006 Evidence-Based Medicine

34. Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial. Full Text available with Trip Pro

Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial. Antidepressant medication is frequently prescribed for patients with anorexia nervosa.To determine whether fluoxetine can promote recovery and prolong time-to-relapse among patients with anorexia nervosa following weight restoration.Randomized, double-blind, placebo-controlled trial. From January 2000 until May 2005, 93 patients with anorexia nervosa received intensive inpatient or day-program treatment (...) at the New York State Psychiatric Institute or Toronto General Hospital. Participants regained weight to a minimum body mass index (calculated as weight in kilograms divided by the square of height in meters) of 19.0 and were then eligible to participate in the randomized phase of the trial.Participants were randomly assigned to receive fluoxetine or placebo and were treated for up to 1 year as outpatients in double-blind fashion. All patients also received individual cognitive behavioral therapy.The

2006 JAMA Controlled trial quality: predicted high

35. Effectiveness and cost-effectiveness of antidepressant treatment in primary health care: a six-month randomised study comparing fluoxetine to imipramine

Effectiveness and cost-effectiveness of antidepressant treatment in primary health care: a six-month randomised study comparing fluoxetine to imipramine Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2006 NHS Economic Evaluation Database.

36. Cognitive therapy is more effective than fluoxetine in people with generalised social phobia Full Text available with Trip Pro

Cognitive therapy is more effective than fluoxetine in people with generalised social phobia Cognitive therapy is more effective than fluoxetine in people with generalised social phobia | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Cognitive therapy is more effective than fluoxetine in people with generalised social phobia Article Text Therapeutics Cognitive therapy is more effective than fluoxetine in people with generalised

2005 Evidence-Based Mental Health

37. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. Full Text available with Trip Pro

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. Initial treatment of major depressive disorder in adolescents may include cognitive-behavioral therapy (CBT) or a selective serotonin reuptake inhibitor (SSRI). However, little is known about their relative or combined effectiveness.To evaluate the effectiveness of 4 treatments among adolescents with major depressive (...) disorder.Randomized controlled trial of a volunteer sample of 439 patients between the ages of 12 to 17 years with a primary Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, diagnosis of major depressive disorder. The trial was conducted at 13 US academic and community clinics between spring 2000 and summer 2003.Twelve weeks of (1) fluoxetine alone (10 to 40 mg/d), (2) CBT alone, (3) CBT with fluoxetine (10 to 40 mg/d), or (4) placebo (equivalent to 10 to 40 mg/d). Placebo and fluoxetine

2004 JAMA Controlled trial quality: predicted high

38. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. (Abstract)

Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed class of antidepressant, yet it is not known whether one SSRI is more effective than another.To compare the effectiveness of 3 SSRIs (paroxetine, fluoxetine, and sertraline) in depressed primary care patients.Open-label, randomized, intention-to-treat trial, with patient enrollment occurring in April-November 1999 (...) .Thirty-seven clinics in 2 US primary care research networks.A total of 573 depressed adult patients for whom their primary care physician thought that antidepressant therapy was warranted and who completed a baseline interview.Patients were randomly assigned to receive paroxetine (n = 189), fluoxetine (n = 193), or sertraline (n = 191) for 9 months. Primary care physicians were allowed to switch patients to a different SSRI or non-SSRI antidepressant if they did not adequately respond to or tolerate

2001 JAMA Controlled trial quality: predicted high

39. Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial

Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial Sacristan J A, Gilaberte I, Boto B, Buesching D P, Obenchain (...) R L, Demitrack M, Sola V P, Alvarez E, Artigas F Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Fluoxetine plus pindolol for patients with depressive disorder. Type of intervention Treatment. Economic study type Cost

2000 NHS Economic Evaluation Database.

40. Economic impact of using mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK

Economic impact of using mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK Economic impact of using mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK Economic impact of using mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK Borghi J, Guest J F Record Status This is a critical abstract of an economic (...) evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population Patients in the UK

2000 NHS Economic Evaluation Database.